Cola cure? Study sheds light on soda’s potential for common holiday medical emergency

Researchers performed a randomized controlled trial (RCT) to evaluate the safety and effectiveness of cola in relieving esophageal meal bolus impaction.

Afib Detected After Stroke: Link to Recurrent Events Questioned

Cryptogenic stroke survivors who went on to get an insertable cardiac monitor (ICM) had a similar risk of recurrent stroke whether or not any atrial

January 23, 2024

Trump administration’s abrupt cancellation of scientific meetings prompts confusion, concern

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the Trump

January 23, 2025

Vivace closes $35m in Series D for cancer drug development

The company is preparing to progress the drug into a registrational Phase III trial for subjects with mesothelioma. Credit: PowerUp/Shutterstock. Vivace Therapeutics has closed $35m

March 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.